DNYUZ
No Result
View All Result
DNYUZ
No Result
View All Result
DNYUZ
Home News

White House pulls FDA nominee amid political pushback

November 18, 2026
in News
White House pulls FDA nominee amid political pushback

The White House on Tuesday night abandoned its nomination of Heidi Overton to lead the Food and Drug Administration amid growing concerns that she could not be confirmed by the Senate, according to a White House official and three other people familiar with the situation who spoke on the condition of anonymity to describe a personnel matter.

Overton had been slated to get a vote Wednesday before the Senate Health, Education, Labor and Pensions Committee, a key hurdle for her candidacy to lead the agency charged with overseeing the safety of drugs, vaccines, tobacco and the majority of the U.S. food supply.

The White House did not immediately respond to a request for comment. Axios first reported that Overton’s nomination was dropped.

In recent days, Trump administration officials had been skeptical that she would succeed, prompting them to discuss whether to attempt to shore up her nomination or abandon it altogether. She received pushback from Democrats and some prominent supporters of the Make America Healthy Again movement championed by Health Secretary Robert F. Kennedy Jr.

Overton had also faced questions and skepticism from some GOP senators who would have been integral to advancing her nomination to the Senate floor.

However, Sen. Bill Cassidy (R-Louisiana), a physician who chairs the Senate health panel, said he believed there was “a viable confirmation path” for Overton.

“I was having productive conversations with members,” Cassidy wrote on social media Tuesday evening. “I believe she would have had the votes to pass out of committee and pass the full Senate.”

Cassidy — who lost his primary after President Donald Trump endorsed a rival and is set to soon leave the Senate — had not previously publicly committed to supporting Overton. On CBS’s “Face the Nation” on Sunday, Cassidy said he had “questions” about her suitability for the role, and said he couldn’t predict the outcome of the vote.

On Tuesday evening, he said his conversations with Overton had convinced him that “she would follow the science and push back against decisions that put Americans’ health at risk.” He asserted that the last remaining issue was that antiabortion senators were seeking “final assurances” from the administration.

Cassidy cast a pivotal vote to help confirm Kennedy as the nation’s top health official, but the two have since clashed on vaccine policy.

Some MAHA activists had expressed concern over the nomination since Overton was selected in August, and celebrated the White House’s decision to pull her.

“CHRISTMAS CAME EARLY,” Alex Clark, a prominent conservative wellness influencer and podcaster aligned with the MAHA movement, wrote in a message. “MAHA PREVAILS.”

Overton, a physician who is board-certified in public health and general preventive medicine, has been serving as the deputy director of the White House’s Domestic Policy Council. In that role, she’s been intricately involved in much of President Donald Trump’s health agenda.

The decision to pull the nomination means that it’s unlikely Trump will have an FDA chief confirmed anytime soon. Democrats’ sweeping victories during the midterm elections mean they will control Congress next year.

Trump selected Overton in August to lead the FDA. The agency has been without a permanent commissioner since Marty Makary resigned in May, after he incurred the frustration of White House officials. His allies have characterized his departure as a matter of principle, saying he had been displeased about allowing the sale of fruit-flavored vapes. Kyle Diamantas, who was previously the agency’s top food official and a senior counselor to Kennedy, has been serving as acting FDA chief, and has received high marks from both career staff and those outside the agency.

Meanwhile, Overton faced questions from Republican senators over vapes, a commonly used abortion pill and vaccines.

Cassidy initially said he had “strong concerns” about Overton’s nomination, pointing to her role in announcing an executive order over the summer that seeks to reduce the childhood vaccine schedule; break up the combined measles, mumps and rubella shot; and space out immunizations.

During her hearing, Cassidy grilled Overton on her stance on vaccines. She said that the combined MMR shot was “not lethal” and was “safe and effective,” which stands in contrast to Trump’s vaccine remarks that, taken “together, there could be a possibility they’re quite lethal.”

Meanwhile, prominent MAHA advocates have been frustrated over Overton’s nomination. They contended that she would not fiercely challenge corporate interests and claimed she was involved in writing an executive order that boosted the production of glyphosate, a commonly used weed killer that they say harms childhood health.

Some White House officials previously rejected that accusation against Overton, saying her role in the White House had been to vet proposals for legal soundness and not based on her personal policy preferences. Kush Desai, a former White House spokesman who is still working in the administration, has said that Overton “pushed as many MAHA-minded edits as possible to a mostly-baked EO that, again, was written with national security considerations in mind.”

Calley Means, a former White House adviser, alleged that Overton worked with the Justice Department to “construct a legal argument” that led to the Supreme Court taking up a case that restricted a massive wave of lawsuits against a chemical giant; he also said she did not consult Kennedy on the matter. Means also alleged that Overton wrote the policy to relax standards on fruit-flavored vapes.

The White House did not comment on the allegations. During her Senate confirmation hearing, Overton said that “there is a 100 percent agreement from this administration that we must protect kids from illegal substances and from vapes and from flavored vapes.” The agency must follow rules weighing whether a product is appropriate for the protection of public health, she added, saying that adults are using flavors to help them quit smoking.

On Friday, a campaign launched depicting Overton as “Heidi Vaperton” and urging senators to oppose her nomination. Posters and yard signs cropped up across D.C. and other cities that showed her holding a vape. The campaign was the work of a group dubbed Health in Office, according to its spokeswoman, Jennifer Kay. She declined to share the activists’ identities but said they were “nonpartisan” and worried about Trump’s health agenda.

Lena H. Sun contributed to this report.

The post White House pulls FDA nominee amid political pushback appeared first on Washington Post.

Andy Jassy isn’t ruling out opening Amazon’s doors to outside AI agents
News

Andy Jassy isn’t ruling out opening Amazon’s doors to outside AI agents

by Business Insider
November 18, 2026

Amazon is open to outside shopping agents if there is a “fair exchange of value,” CEO Andy Jassy said. Jae ...

Read more
News

Hone Health lands $228 million with backing from Jay-Z’s firm and Gwyneth Paltrow. She’s an investor—and a patient

November 18, 2026
News

Are There Really 59,000 Empty Rent-Stabilized Apartments in New York?

November 18, 2026
News

POWs, teens among 6 US soldiers from Korean War identified seven decades later

November 18, 2026
News

Pentagon Pete’s Prayer Service Takes Dark Turn

November 18, 2026
White House pulls FDA nominee amid political pushback

White House pulls FDA nominee amid political pushback

November 18, 2026
Palmer Luckey wants to build US industries on the ocean to sidestep ‘ill-considered’ laws

Palmer Luckey wants to build US industries on the ocean to sidestep ‘ill-considered’ laws

November 18, 2026
Rubio Says Cause of Tech Failures Isn’t Hackers, It’s Likely Us

Rubio Says Rush to Secure Systems May Be Causing Failures

November 18, 2026

DNYUZ © 2026

No Result
View All Result

DNYUZ © 2026